Metabolic Syndrome and Cardiometabolic Risk Factors.

This article reviews the evidence that demonstrates that individuals with the MetS are at increased risk for CVD incidence and mortality and discusses these debated issues.
PMID: 24168440 [PubMed - as supplied by publisher]

Source: Current Vascular Pharmacology - October 30, 2013 Category: Drugs & Pharmacology Authors: Papakonstantinou E, Lambadiari V, Dimitriadis G, Zampelas A Tags: Curr Vasc Pharmacol Source Type: research